Amgen/UCB reveal new osteoporosis drug dataBut romosozumab missed secondary endpoint of non-vertebral fractures Share XAmgen/UCB reveal new osteoporosis drug datahttps://pharmaphorum.com/news/amgenucb-reveal-new-osteoporosis-drug-data/